AKR1C2 and cancer: Overexpression of AKR1C isoforms, AKR1C1, AKR1C2, and AKR1C3, is associated with drug resistance in patients with various cancers, including stomach, lung, ovary, and colon cancer16, 17, 18, 19, 20.